30 April 2020

GC Group led by Dr. Kongkrapan Intarajang, CEO of GC, along with his executive team, present CoviClear, or the silver nanoparticle disinfection unit, to help reduce the risk of contracting COVID-19

Share:

GC Group led by Dr. Kongkrapan Intarajang, CEO of GC, along with his executive team, present CoviClear, or the silver nanoparticle disinfection unit, to help reduce the risk of contracting COVID-19 to Somdej Phranangchaosirikit Hospital’s Naval Medical Department

GC Group, led by Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented the silver nanoparticle disinfection unit CoviClear, which is designed to help lower the risk of contracting COVID-19, along with raw materials to produce two types of disinfectant liquid: triethanolamine, for which GC is the only manufacturer in Thailand, and pharmaceutical-grade glycerine for use in CoviClear, to Somdej Phranangchaosirikit Hospital, Naval Medical Department. Adm. Sittiporn Maskasem, Chief of Staff (COS) of Royal Thai Navy, and Vadm. Prachachart Sirisawat, Deputy Chief of Staff of Royal Thai Navy, were on hand to receive the donation.

CoviClear is an innovation developed by GC that increases the disinfection and prevention of germs by releasing silver nanoparticles through a micron-sized nozzle in the form of a vapor. The vapor pairs the silver nanoparticles with viruses, bacteria and other diseases which a person carries, including on their clothing, killing them on contact without causing any harm.

News

News
07 October 2022
GC Joins with GPSC to Launch the Floating Solar Power Project In Line with the “Together to Net Zero” Goal
Read More
News
13 November 2021
GC Rated Number One for Three Consecutive Years in the World in the DJSI Chemicals Sector, As It Transitions into Net Zero Organization
Read More
News
01 October 2020
GC, ThaiBev, and Thai Union Join Forces to Strengthen Partnerships at the “Thailand Sustainability Expo 2020”
Read More